Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)

Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses

(2013) Varun Warrier et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis

(2013) Rebecca E.H. Whiting et al.   EXPERIMENTAL EYE RESEARCH

Enzyme replacement therapy for lysosomal storage diseases

(2011) Robin H. Lachmann   CURRENT OPINION IN PEDIATRICS

Progressive conduction defects and cardiac death in late infantile neuronal ceroid lipofuscinosis

(2011) SHINOBU FUKUMURA et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis

(2011) D. N. Sanders et al.   GENES BRAIN AND BEHAVIOR

Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis

(2011) Brian R. Vuillemenot et al.   MOLECULAR GENETICS AND METABOLISM

Therapy for the mucopolysaccharidoses

(2011) V. Valayannopoulos et al.   RHEUMATOLOGY

New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases

(2010) Jeffrey H. Grubb et al.   REJUVENATION RESEARCH

Morphologic Changes Associated with Intrathecal Catheters for Direct Delivery to the Central Nervous System in Preclinical Studies

(2010) Mark T. Butt   TOXICOLOGIC PATHOLOGY

The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease

(2009) Chantal F Morel et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis

(2008) Michael Chang et al.   MOLECULAR THERAPY